Cliff Asness AQR Capital Management
Cliff Asness is a co-founder of AQR Capital Management, a leading quantitative investment firm spanning equities, alternatives, and factor strategies. He is known for academic-informed research on value, momentum, and other systematic premia, as well as candid market commentary. Asness’s work bridges academic finance and large-scale institutional portfolio management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
EOG Resources
EOG
|
+$143M |
| 2 |
WNR
Western Refining Inc
WNR
|
+$142M |
| 3 |
DTV
DIRECTV COM STK (DE)
DTV
|
+$137M |
| 4 |
BHI
Baker Hughes
BHI
|
+$135M |
| 5 |
POM
PEPCO HOLDINGS, INC.
POM
|
+$113M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BEAM
BEAM INC COM STK (DE)
BEAM
|
+$215M |
| 2 |
LSI
LSI CORPORATION
LSI
|
+$185M |
| 3 |
Omnicom Group
OMC
|
+$165M |
| 4 |
BRE
BRE PROPERTIES INC CL A
BRE
|
+$95M |
| 5 |
JOSB
JOS A BANK CLOTHIERS INC
JOSB
|
+$83M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.95% |
| 2 | Technology | 13.55% |
| 3 | Financials | 10.47% |
| 4 | Energy | 10.33% |
| 5 | Industrials | 9.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EVM
1651
DELISTED
Eaton Vance California Municipal Bond Fund
EVM
| $804K | ﹤0.01% |
69,428
-6,387
| -8% | -$72.4K |
|
1652
Radian Group
RDN
$4.86B
| $804K | ﹤0.01% |
54,274
+9,000
| +20% | +$131K |
|
1653
Children's Place
PLCE
$58M
| $803K | ﹤0.01% |
16,181
-47,400
| -75% | -$2.3M |
|
1654
Nordson
NDSN
$18.6B
| $802K | ﹤0.01% |
10,000
-300
| -3% | -$23.1K |
|
1655
Encore Capital Group
ECPG
$2.19B
| $801K | ﹤0.01% |
17,640
-300
| -2% | -$13.3K |
|
|
FSYS
1656
DELISTED
FUEL SYSTEMS SOLUTIONS INC COM STK
FSYS
| $800K | ﹤0.01% |
71,800
-16,500
| -19% | -$171K |
|
1657
Opko Health
OPK
$1.1B
| $799K | ﹤0.01% |
90,344
-4,585
| -5% | -$40K |
|
|
RSE
1658
DELISTED
ROUSE PPTYS INC COM (DE)
RSE
| $799K | ﹤0.01% |
46,700
-113,600
| -71% | -$1.9M |
|
1659
Quest Diagnostics
DGX
$26.9B
| $798K | ﹤0.01% |
13,589
+1,000
| +8% | +$58.6K |
|
|
EXAM
1660
DELISTED
EXAMWORKS GROUP INC COM STK (DE)
EXAM
| $798K | ﹤0.01% |
25,161
+3,800
| +18% | +$125K |
|
1661
Hecla Mining
HL
$13.7B
| $793K | ﹤0.01% |
229,900
| – | – |
|
1662
CorVel
CRVL
$3.6B
| $792K | ﹤0.01% |
52,584
+15,300
| +41% | +$238K |
|
|
COHR
1663
DELISTED
Coherent Inc
COHR
| $791K | ﹤0.01% |
11,951
+800
| +7% | +$49.5K |
|
1664
Toro Company
TTC
$9.47B
| $789K | ﹤0.01% |
24,800
+7,400
| +43% | +$236K |
|
1665
PRA Group
PRAA
$759M
| $788K | ﹤0.01% |
13,236
+300
| +2% | +$17.1K |
|
|
UIL
1666
DELISTED
UIL HOLDINGS
UIL
| $788K | ﹤0.01% |
20,352
| – | – |
|
1667
AtriCure
ATRC
$2.51B
| $787K | ﹤0.01% |
42,800
+13,000
| +44% | +$216K |
|
|
ARG
1668
DELISTED
Airgas Inc
ARG
| $787K | ﹤0.01% |
7,230
-6,887
| -49% | -$736K |
|
1669
8x8 Inc
EGHT
$286M
| $785K | ﹤0.01% |
97,202
-57,100
| -37% | -$500K |
|
|
FCS
1670
DELISTED
FAIRCHILD SEMICONDUCTOR INTL INC COMMON
FCS
| $785K | ﹤0.01% |
50,300
+35,800
| +247% | +$505K |
|
|
CPE
1671
DELISTED
Callon Petroleum Company
CPE
| $784K | ﹤0.01% |
+6,730
| New | +$666K |
|
1672
Clearfield
CLFD
$370M
| $781K | ﹤0.01% |
46,514
+13,600
| +41% | +$248K |
|
1673
Rockwell Medical
RMTI
$31.8M
| $776K | ﹤0.01% |
588
| – | – |
|
|
GBL
1674
DELISTED
GAMCO Investors, Inc.
GBL
| $776K | ﹤0.01% |
17,352
+5,571
| +47% | +$232K |
|
|
GEVA
1675
DELISTED
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
| $776K | ﹤0.01% |
7,400
+1,800
| +32% | +$153K |
|
Similar funds
Cliff Asness's Q2 2014 Portfolio in Review
As of Q2 2014, Cliff Asness held 2,714 positions worth $37.1B, up 12% from $33.1B the previous quarter. Its ten largest holdings account for 8.6% of the portfolio.
Cliff Asness's Q2 2014 filing shows 178 new, 1,030 increased, 953 reduced and 205 closed positions. Its largest new stake was AstraZeneca: 1,186,418 shares worth $88.2M. The largest sale was BEAM INC COM STK (DE), an estimated $215M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 15% a quarter earlier, followed by Technology and Financials.
- Cliff Asness's largest Q2 2014 buy was AstraZeneca: 1,186,418 shares worth $88.2M.
- Cliff Asness added most to EOG Resources in Q2 2014, an estimated $143M increase.
- Cliff Asness's biggest Q2 2014 reduction was Omnicom Group, cutting an estimated $165M.
- Cliff Asness fully exited BEAM INC COM STK (DE) in Q2 2014, selling an estimated $215M.
- Cliff Asness's ten largest holdings make up 8.6% of its $37.1B portfolio in Q2 2014.
- Cliff Asness opened 178 new positions and closed 205 in Q2 2014.
- Cliff Asness's portfolio value rose 12% quarter-over-quarter to $37.1B.
Based on AQR Capital Management's 13F filing for Q2 2014, filed 14 Aug 2014.